International Journal of Technology Assessment in Health Care

Article	Citations
OP123 The Use Of Surrogate Outcomes In National Institute For Health And Care Excellence (NICE) Highly Specialised Technology Evaluations: A Review Of Published Guidance	158
OP312 Developing A Tool-kit For Assessment Of Autism Spectrum Disorder	27
PP94 Pandemic Preparedness: EUnetHTA COVID-19 Rapid Response With “Rolling Collaborative Reviews (RCR)”	21
PP114 The Influence Of Implicit Factors On The Health Technology Assessment Deliberative Process: A Survey In Five European Countries	18
PP150 The Role Of Expert Consensus In UK Guidance: Patient Selection For Hydrogel Spacer Use During Prostate Cancer Radiotherapy	16
PP97 Recommendations For Generating South African Health-Related Quality Of Life Data For Cost-Utility Analyses	16
PP53 Applying The VALIDATE Approach To Frame The Assessment Of Integrated Care Management In Aortic Valve Stenosis	16
PD35 Mortality And Risk Factors Associated With Dialysis Patients With COVID-19 In A Brazilian Supplementary Health Service	15
PD09 Comparing Long-term Costs Associated With Intraocular Lens Selection And Nd:YAG Laser Capsulotomy In The UK: A Cost-Consequence Analysis	15
OP42 Increasing Access To Real-World Data To Move From Health Technology Assessment To Health Technology Management	15
PP47 Modelling Non-small Cell Lung Cancer Treatment: Predicted and Observed Impact Of Immunotherapy In The Netherlands	14
OP92 Impact Of Real-World Evidence On Health Technology Assessment And National Guidance For Interventional Procedures: A UK Perspective	13
PP23 Lost In Translation? The Differences In The Use Of Real-World Evidence Across Key Markets	13
OP60 Methodological Guidance And Doctrine Of The French National Authority For Health For Economic Evaluation	13
PP97 How Health Technology Agencies Estimate Target Population Size For Medical Devices: The Example Of Spinal Cord Stimulation	12
OP82 Positron Emission Tomography Combined With Computed Tomography Using 18F-Sodium Fluoride	12
OP128 Uncertainties In The Cost-Effectiveness Analysis Of Onasemnogene Abeparvovec For Spinal Muscular Atrophy Type 1	11
PP38 Designing A Training And Capacity Building Pathway In Patient Involvement	9
Methods and criteria for the assessment of orphan drugs: a scoping review	9
PP79 Publication Trends Of Network Meta-analyses In Europe And Asia: A Focus On Cardiovascular Disease	9
OP19 Exploring The Environment/Capacity Of South African Citizen Actors To Contribute To Health Technology Assessment Processes, Policy Development And Institutionalization	9
PP105 Efficacy, Effectiveness And Safety Of Letermovir For Prophylaxis Of Cytomegalovirus Infection And Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation	9
PP11 Patient Involvement In Drug Evaluations To Inform Funding Decisions: A Singapore Case Study	9
Mapping frameworks for synthesizing qualitative evidence in health technology assessment	8
Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injury	8

PD129 Extension Of An Influenza Vaccination Program To Include Those Aged 50 To 64 Years: A Rapid Health Technology Assessment Approach	7
PD149 Comparison Of The Draft European Union Health Technology Assessment Template With Germany’s AMNOG Template	7
PP56 National Immunization Technical Advisory Groups Are Essential For Successful Implementation Of The European Health Technology Assessment Regulation	7
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis	7
OP76 Cost-Effectiveness Of Offering Human Papillomavirus Self-Sampling To Non-Attendees Of Organized Primary Cervical Cancer Screening In Germany	7
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report	7
PD10 Cost Effectiveness Analysis Of Etranacogene Dezaparvovec Versus Factor IX Prophylaxis In Adult Men With Hemophilia B From Brazil	6
PD208 Optimal Scheme For Molecular Diagnosis Of BRCA1/2 Gene Mutations In Patients With Breast Cancer In Poland - Cost-Utility Analysis	6
PP07 One Bad Apple Can Spoil The Barrel: Are We Effectively Evaluating Software As A Medical Device?	6
OP25 Rapid Molecular Tests For Detecting Multidrug-Resistant Microorganisms: An Overview Of Systematic Reviews Within A Living Evidence Project	6
A model-based study to estimate the health and economic impact of health technology assessment in Thailand	6
OD12 Large Language Models As Powerful Tools In Health Technology Assessment	6
PD137 Reviewing The Health Technology Assessment And Regulatory Policy Landscape On Acceptability Standards For Real-World Evidence - Initial Findings	6
PP92 Enhancing Patient Engagement In Health Technology Assessment: Identification Of Barriers, Facilitators, And Proposals For Improvement	6
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies	5
PP09 Use Of Real-World Evidence For Managing Health Technologies Throughout The Life Cycle Of Transcatheter Aortic Valve Interventions	5
Health technology assessment in traditional and complementary medicine: a scoping review of international activity and examples of acupuncture	5
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review	5
OP90 Optimizing Health Technology Assessment And Appraisal For Orphan Drug Reimbursement: Experiences And Tools For Improvement	5
Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum	5
PP118 Cyclic Mental Health Technology Assessment with Priority Setting And Involving Stakeholders - A Case Report From The Netherlands	5
PP149 A Multidimensional And Multistakeholder Approach: Assessing Ethical, Legal, Organizational, Social or Patient-centered (ELSI+) for Telemedicine In Neurological Diseases	5
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities	4
PP259 Invisible Resilience: The Value Of Medical Technology In Reducing Population And Health Systems’ Vulnerability To COVID-19.	4
PP146 Seeing Eye-To-Eye on Real-World Evidence: Are Guidance from Japan and China Consistent with Recommendations from REALISE in Asia?	4
OP126 Clinical And Economic Evaluation Of The Effectiveness Of Cerebrolysin® In Neurological Patients With Post-Stroke Complications In Kazakhstan	4
Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks	4
OP46 The Decision Uncertainty Toolkit: Risk Measures And Visual Outputs To Support Health Technology Decision-making During Public Health Crises	4
Acknowledgments	4
OP181 Adapting Evidence To Produce A Health Technology Assessment Of Mammography Screening: An Example From The West Bank	4
OP27 Impact Of Generic Entry Of Pharmaceuticals On Drug Prices In Australia	4
OP167 An Analysis Of Medication Exclusion Reports In The Health Technology Assessment Process For The Brazilian Unified Health System	4
Health technology assessment and healthcare environmental sustainability: Prioritizing effort and maximizing impact	4
PP165 Bridging The Gap Of Health Services During The COVID-19 Pandemic Through Telemedicine	4
OP129 The Use Of A Text-Mining Screening Tool For Systematic Review Of Treatments For Relapsed/Refractory Diffuse Large B-Cell Lymphoma	4
OP176 Integrating Real-world Compliance In The Assessment Of Left Atrial Appendage Closure Versus Anticoagulation Therapy In Non-valvular Atrial Fibrillation	4
Use of surrogate endpoints in health technology assessment: a review of selected NICE technology appraisals in oncology	4
Results of health technology assessments of orphan drugs in Germany—lack of added benefit, evidence gaps, and persisting unmet medical needs	4
PP195 Cost Utility Of Transcatheter Aortic Valve Implantation For Patients With Inoperable Severe Aortic Stenosis In Brazil	3
PD33 Development And Validation Of A Machine Learning-Based Prediction Model For COVID-19 Diagnosis Using Patients’ Metabolomic Profile Data	3
OD11 Application Of Natural Language Processing To Predict Final Recommendation Of Brazilian Health Technology Assessment Reports	3
PD203 Comparison Of Health Technology Assessment Methodologies Across Australia, Canada, New Zealand And The United Kingdom: Implications For Future Collaboration	3
Acceptability of Manufacturer-Proposed Utility Values for NICE Cancer Medicine Appraisals: Analysis of Manufacturers’ Information Sources	3
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect	3
PP70 Mapping Of Health Technology Assessment In China: A Comparative Study Between 2016 And 2021	3
OP51 Use Of Real-World Data In Cost-effectiveness Analysis Of Sequential Biologic Treatment For Rheumatoid Arthritis	3
A review of HTA guidelines on societal and novel value elements	3
Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling	3
PP09 Fecal Immunochemical Tests For Patients With Symptoms Suggestive Of Colorectal Cancer: A Systematic Review And Multiple-Threshold Meta-Analysis	3
The role of health economics within health technology assessment: past, present, and future – an Austrian perspective	3

OP80 Generating Patient Preference Evidence For Health Technology Assessment: A Sustainable Roadmap	3
Economic evaluation of genomic/genetic tests: a review and future directions	3
OP218 Searching Preprint Repositories For COVID-19 Therapeutics Using A Semi-Automated Text-Mining Tool	3
PP275 Incorporating Quality-Of-Care Indicators In Health Economic Modelling: A Case-Study On Surgical Site Infections In Cardiac Surgery	3
OP199 From Pilot Studies To System-Wide Innovation: Challenges And Opportunities For Clinical Decision Support Systems (CDSS) Implementation In Australia	3
A first exploration of the economic consequences of an autonomous surgical robot for lateral skull base surgery: an early health technology assessment	3
PD71 Survival Outcomes And Adherence To Defined Daily Doses Of Imiglucerase: A 16-Year Brazilian Cohort Study In Gaucher Disease	3
PERCEPTION OF NON-LAYPERSON ADVISORY COMMITTEE MEMBERS ON THE APPLICATION OF A DISCRETE CHOICE EXPERIMENT INSTRUMENT TO PATIENTS AND ADVISORY COMMITTEE MEMBERS: A QUALITATIVE STUDY	3
The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey	3
Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach	3
PD42 Should Antibiotics Be Used To Treat Recurrent Otitis Media In Children? Updating A Recommendation	2
PD231 A New Way Of Identifying And Selecting Health Technology Assessment Topics: Using Social Media And Citizen Involvement	2
Patient perspectives on continuous glucose monitoring system (CGMS) for diabetes in Malaysia: a vital voice in health technology assessment (HTA) informing decision-making	2
OP105 Gaps, Challenges And Priorities For Neurodegenerative Disease Research And Health Technology Assessment	2
PP55 Health Technology Assessment Scoping Definition For Health Regulation	2
PD22 Exploratory Analysis of a Brazilian Real-World Open Database Applied to Prostate Cancer	2
Advancing cooperation in Health Technology Assessment in Europe: insights from the EUnetHTA 21 project amidst the evolving legal landscape of European HTA	2
OP163 Applying A Local Economic Evaluation Framework To Make Evaluations More Relevant For Local Decision Makers	2
Optimizing red blood cell transfusion practices in the intensive care unit: a multi-phased health technology reassessment	2
A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK	2
PD186 Treat-To-Target In Gout: Are Private General Practitioners In Malaysia Riding The Evidence-Based Wave?	2
OD39 Evaluation Of Sustainability And Environmental Impact Measures In Health Technology Assessment Of Medical Technologies In Europe: Starting An Important Journey	2
OD14 Harmonization Of HTA For Digital Health Technologies: The EU-Funded European Digital Health Technology Assessment Project	2
PP111 Reimbursement And Payment Models: A Survey Of Stakeholders’ Current Experiences And Future Outlook Within The Dutch Policy Setting	2
OP01 Impact Of Cost Heterogeneity On Assessing The Value Of Gene Therapies	2
OP44 Does The Health Economic Modelling Structure Matter? An External Validation Of Three Approaches Commonly Used In Obesity Modelling	2
OP136 A Comparison Of Health Technology Assessment Recommendations In Australia, Canada, And England: Is There Opportunity For Further Alignment?	2
Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment	2
Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders’ perspectives	2
PD199 Global Collaboration Post-Brexit: Do Project Orbis And The Access Consortium Improve Access In The UK Compared With Europe?	2
PD177 The Effect Of COVID-19 On Cancer Screening In Brazil, Canada, And The USA: A Cross-National Study	2
PD133 Exploring Real-World Data Based Financing Models For Lung Cancer Immunotherapy In The Czech Republic	2
PD124 Genicular Artery Embolization For The Treatment Of Knee Osteoarthritis: A Systematic Review And Meta-analysis	2
OP65 An Overview Of Participatory Approaches, Stakeholders, Methods, Topics and Challenges In Medical Device Development: A Scoping Review	2
PP57 Outcomes Model For Assessing Strategies Improving In Vitro Fertilization Birth Rates	2
Patient-based evidence: its role in decision making on end-of-life, orphan, and ultra-orphan medicines	2
Acceptability of self-administered antigen test for COVID-19 in the Philippines	2
Analysis of consumer comments into PBAC decision-making (2014–9)	2
PD05 Novel Non-Thermal Ablation Technology For The Treatment Of Atrial Fibrillation	2
PP34 Impact Of The COVID-19 Pandemic On Depression Incidence And Healthcare Service Use Among Patients With Depression	2
PP37 Guidance On Using Hospital-Based Real-World Evidence In Health Technology Assessments For Oncology	2
PD60 The Importance Of Systematic Reviews Addressing Questions Of Prevalence In Health Technology Assessment	1
PD07 Cost-Effectiveness Of Direct Oral Anticoagulants In Chinese Patients With Non-Valvular Atrial Fibrillation	1
PP22 A Lifecycle Approach To The Use Of Real-World Evidence In HTA Submissions And Resubmissions: A Decade’s Experience	1
OP244 Tools And Experiences To Facilitate Effective Patient Participation In Health Technology Assessment	1
PD56 Conceptual Issues In The Valuation Of Health States In Children	1
Implementing a sandbox approach in health technology assessment: benefits and recommendations	1
OP34 Horizon Scanning A Matter Of Collaboration. A Description Of The Processes Of I-HTS Member Organizations	1
OP74 Analysis Of Literature And Research Foci In Overdiagnosis Based On Citespace	1
OP83 Diagnostic Accuracy And Cost Effectiveness Of Automated Ankle Brachial Pressure Index Measurement For Peripheral Arterial Disease In People With Leg Ulceration	1
PD39 First Approach For Assessing Statistical Significance In Industry Funded Matching-Adjusted Indirect Comparison Studies: A Scoping Review	1
OD30 Clinician-Driven Health Technology Assessment: National Cancer Medicines Review For Off-Label Uses And On-Label Off-Patent Uses In NHSScotland	1
OP35 Early Access To Medicinal Products In France: A Positive Evaluation Two Years Into The New Framework	1
PD96 Are Continuous Noninvasive Blood Pressure Monitoring Devices Accurate Enough To Replace Invasive Monitoring? A Rapid Review	1
OD37 How The PICOTS-ComTeC Framework For Digital Health Interventions Can Be Useful For Health Technology Assessment	1
OP13 Improving Case Finding For Celiac Disease In Children And Adults: Evidence Synthesis And Economic Modeling	1
PP219 Combining Healthcare Solutions For Cataract Surgery. An Incremental Benefit Analysis From The Perspective Of The Russian Healthcare System	1
PD119 Interventions To Improve Long COVID Symptoms: A Systematic Review Of Randomized Controlled Trials	1
PD50 Does The New Healthcare Reform Improve Job Satisfaction Among Village Clinic Doctors In China? A Meta-Analysis	1
PP14 Value-Based Pricing For Advanced Therapy Medicinal Products: Emerging Affordability Solutions	1
Response to heterogeneity of tests and platforms in economic evaluations: synthetic model adoption; derivatives of transferable practice	1
OP79 Incorporating Environmental Impacts Into Health Technology Assessment: An Examination Of Potential Approaches And Challenges	1
Health technology assessment for oral health in the past decade: a scoping review	1
PP120 Fluorescent In Situ Hybridization (FISH) Vs Conventional Cytogenetic (CC) For Detecting High-Risk Genetic Mutations In Multiple Myeloma	1
OP83 Joining Efforts To Improve Patient Involvement In Health Technology Assessment: The Case Of The RedETS Patient Interest Group	1
OP279 Data Protection In The European Union Post-General Data Protection Regulation (GDPR): A Barrier Or An Enabler Of Pharmaceutical Innovation?	1
PP108 Multidimensional Analysis Of Peristeen Plus Medical Device	1
OP70 Implementation Of An Online Consultation Hub To Facilitate Consumer Engagement In Health Technology Assessment Processes	1
PP100 Improving The Assessment Of Effectiveness For Digital Applications Using The B Statistic: Using WtsWrng As A Case Study	1
OP81 Do Sustainable Healthcare Principles Inform Guidance Development? An Exemplary Case Study In Respiratory Care	1
PD185 Is The Incorporation Of Medications For Ultrarare Diseases In Brazil Predominantly Driven By Costs? A Shift In Paradigm	1
PP109 Which Review Is Right For You? Choosing A Review Methodology	1
PD173 Semi-Automation Of Systematic Literature Review Title And Abstract Screening Using Text Mining And Classification Techniques	1
Lifecycle evaluation of medical devices: supporting or jeopardizing patient outcomes? A comparative analysis of evaluation models	1
INAHTA member agency stories of engaging, adaptable, and impactful HTA	1
Expanding access to sodium-glucose cotransporter 2 inhibitors (SGLT2i) in the Ministry of Health Malaysia – a multiple HTA approach	1
OP248 A Minimum Data-Set For Left Ventricular Assist Device On Destination Therapy: Cross-Border Collaboration Pilot On Real World Data	1
Calibration of transition probabilities to model survival of adjuvant trastuzumab for early breast cancer in Indonesia	1
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France	1
PP222 Efficacy And Safety Of Foot Reflexology	1

PP87 Glecaprevir/pibrentasvir (Maviret®) Remains A Cost-effective Treatment For Chronic Hepatitis C Virus Infection After Changes To The Treated Population	1
A systematic literature review of revealed preferences of decision-makers for recommendations of cancer drugs in health technology assessment	1
PD61 Thromboprophylaxis After Major Orthopedic Surgeries: Health Technology Assessment To Promote Access To Oral Anticoagulants	1
PP41 COVID-19 Modeling To Support Decision Making In Brazil: A Scoping Review	1
PP153 Efficacy And Safety of Onasemnogene Abeparvovec For The Treatment Of Patients With Spinal Muscular Atrophy Type 1: Meta-Analysis	1
PP33 Molecular Markers For The Detection Of Clinically Significant Prostate Cancer	1
OP67 Considerations Of Treatment Novelty In Health Technology Assessment	1
A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic	1
OP54 The Early Detection And Warning System ‘SINTESIS-New Technologies’: A Horizon Scanning Experience In Spain	1
OD33 Assessment Tool For MHealth Apps To Manage Depression (EvalDepApps Project)	1
PD32 Cost-Utility Of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres For Chemotherapy-Refractory Metastatic Colorectal Cancer In Brazil	1
OP98 Improving Patient Involvement In Health Technology Assessments: Is It Enough To Train Just The Patients?	1
OP43 Incorporating Mathematical Modeling To Improve Accuracy Of Budget Impact Analysis: Using Screening For Hepatitis C As An Example	1
PP53 Potential Cost-Effectiveness And Innovation Headroom Of A More Accurate Companion Diagnostic For PD-L1 In Non-Small-Cell Lung Cancer	1
PP43 Budget Impact Analysis Of Next-Generation Sequencing Coverage In Taiwan’s National Health Insurance	1
The relative importance of severity and rarity criteria in health resource allocation: an umbrella review	1
OD41 Conducting Systematic Reviews On Rare Diseases: Lessons Learned From The European Reference Networks Guidelines Programme	1
OP69 Are Artificial-Intelligence-Based Literature Reviews Accepted By Health Technology Assessment Bodies?	1
European Network for Health Technology Assessment’s Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics	1
Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape	1
OP31 Monitoring Of The Budget Impact Determinants Of Incorporated Technologies For Rare Diseases In The Brazilian Health System	1
PD155 RedETS Horizon Scanning: Impact In The Decision-Making Process	1
PP129 Health Technology Assessment Adaptation: Pharyngolaryngeal Biopsies (OLB) For People with Suspected Head and Neck Cancer in the Outpatient Setting	1
Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting	1
PP86 Systematic Review Toolbox 2.0: Rebuilding Toolbox With A Novel Taxonomy To Classify And Share Evidence Synthesis Tools	0
PP12 Projecting The Potential Impact Of Disease-Modifying Therapies For Alzheimer’s Disease On The Carbon Emissions From Hospital Bed-Days in the UK	0
PP133 What Services And Products Should A Health Technology Assessment Agency Provide?	0
PP123 Fair Drug Pricing: Review Of Literature And Models	0
PP67 What Patients Want – Optimizing Oncology Value Assessment To The Goals Of Patients	0
PP45 Core Outcome Sets For Research And Core Outcome Sets For Routine Care: Do They Overlap?	0
Early Dialogues for Pharmaceutical Products in European Network for Health Technology Assessment Joint Action 3: What Was Done and Where to Go in the Future	0
PD223 Early Dialogue With Researchers: The Case Of The OPTIBIO Study, Innovating From The Investigation Stages	0
PD141 Health Technology Assessment Methodology Approach For Precision Personalized Medicine: An Innovative Public Procurement Case Study	0
PD197 Improving The Impact Of Health Technology Assessment Reports: Experience Of The Synthesis In Catalonia	0
OP24 How Does Robotic-Assisted Surgery Real-World Evidence Complement Randomized Controlled Trials Evidence? A Systematic Literature Review And Meta-Analysis	0
PP78 Data Extrapolation With Survival Curves: An Alternative Approach With Aggregated Data	0
PP41 Using Medicare Claims Data To Support Reimbursement Of A Novel Leadless Pacing System For The Management Of Bradycardia	0
PP78 Effectiveness And Safety Of The FreeStyle Libre® Glucose Monitoring System For T1DM In Childhood And Adolescence	0
Acknowledgements	0
OP57 The Identification Of Technological Innovations To Address The Challenge Of Antimicrobial Resistance Using Horizon Scanning Approaches	0
OP171 Canadian Disease Registry Inventory: Environmental Scan Of The Literature	0
Health technology assessment of medicinal products in Greece: a 5-year (2018–2023) review of timelines and productivity	0
PD14 A New Equitable Biomedical Research And Development Model: Preliminary Findings From A Pilot Study Applying VALIDATE Value Methods	0
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities – Erratum	0
How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies	0
PD40 Antigen Diagnostic Tests With Self-Collection Of Biological Material For The Diagnosis Of COVID-19	0
OP41 Pharmaceutical Technologies Conditionally Approved By The National Institute For Health And Care Excellence: A Critical Analysis	0
PD94 Adapting Existing Evidence-Based Clinical Practice Guidelines: A Case Example with Sexually Transmitted Infections Guidelines In Catalonia, Spain	0
PP102 Impact Of Placing Peripherally Inserted Central Catheters At Patient Bedside Versus Radiology Suite In A Private Australian Hospital	0
OP21 A Critical Review Of Existing Health Inequality And Health Inequity Frameworks In Evidence Synthesis	0
OP121 Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer	0
OP33 Advancing Patient Experience Data Implementation In Reimbursement Decision-Making: Insights On Challenges And Opportunities From Multistakeholder Interviews	0
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders	0
PP62 Improving Patients’ Access To Medicines Through Health Technology Assessment In Ukraine: Measuring The Impact Of The National HTA Roadmap	0
PD230 The VALUE Project: Multistakeholder Assessment For A Value-Based Prevention of Vaccine-Preventable Lower Respiratory Tract Diseases	0
PD59 Review Of The International Epidemiology Of Long COVID	0
Early access schemes for innovative health technologies: the views of international stakeholders	0
PP108 A Systematic Review Of Reactogenicity And Safety Of Recombinant Zoster Vaccine For Prevention Of Herpes Zoster In Adults	0
PD29 Using Different Parametric Distributions In Partitioned Survival Analysis: Impact On Incremental Cost-Utility Ratio In A Proportional Hazards Model	0
OP71 Patient Disease Strategy: A New Operational Framework For Collecting And Applying Patient Experience Data Into Clinical Development Programs	0
OP149 How To Improve The Impact Of Health Technology Assessment: Stakeholders’ Perspectives In Spain	0
OP14 Involving People With A Lived Experience When Developing A Proposed Health Technology Assessment Of Pelvic Organ Prolapse Treatments	0
PP14 The Role Of Health Technology Assessment In The Public Hospitals Of The National Health Service Of Catalonia	0
HTA capacity building in Asia: towards one goal	0
PP83 Economic Impact Of Missed Vaccinations On The Italian National Health System	0
A genuine need or nice to have? Understanding HTA representatives’ perspectives on the use of patient preference data	0
PD16 Reassessment And Selection Strategy Of Dipeptidyl Peptidase-4 Inhibitors For Ministry Of Health Malaysia Medicine Formulary	0
PP89 The Investigation And Development Of A National Formulary Monitoring System Across Wales	0
OP55 Classification System For Innovative Medicines In The Pipeline: New Or Repurposed?	0
PD49 Developing Evidence-Based Optimal Testing Strategies To Monitor Long-Term Conditions In Primary Care	0
Health technology assessment (HTA) readiness in Uganda: stakeholder’s perceptions on the potential application of HTA to support national universal health coverage efforts	0
OP28 Health Technology Assessment: A Situation Analysis Of Zimbabwe	0
OP18 Laying The Foundation For Sustainable Health Technology Assessment Training Program In Ukraine	0
EUnetHTA’s contribution to the new legal framework for health technology assessment cooperation in Europe	0
PP96 Continuous Innovation In Neurostimulation Therapies For The Management Of Chronic Pain: Challenges For Health Technology Assessment Policy	0
PP61 A Decade Of Enhanced Patient And Citizen Involvement In Health Technology Appraisal In Scotland	0
Early technology review: towards an expedited pathway	0
PD135 Real-World Evidence On The Effects Of Robotic Prostatectomy In Poland	0
OP21 Long-Term Cost-Effectiveness Of IDegLira Versus Basal-Bolus Insulin Therapy In Patients With Type 2 Diabetes In Chinese Setting	0
OP81 Experience Matters: A Discrete Choice Experiment Exploring Patient Preferences For Heart Valve Procedures	0
PP88 An Exploratory Analysis Of The Potential Cost-Benefit Of Delaying Kidney Disease Progression In Australia	0
PD104 Percutaneous Ethanol Injection In Thyroid Nodular Pathology And Metastatic Cervical Adenopathies: A Systematic Review, Meta-Analysis, And Economic Evaluation	0
PP138 Awareness Of Health Technology Assessment And Its Predictors Among Medical Students In Public Universities In Klang Valley, Malaysia	0
OP196 Clinical Decision Support Systems (CDSS) For Antibiotic Management: Factors Limiting Sustainable Digital Transformation	0
PP13 Results Of An International Survey About Barriers In Patient Involvement In Health Technology Assessment Of Digital Health Technologies	0
PD40 Pilot Healthcare Programs - Bridging The Evidence Gap For Innovative Technologies	0
PP52 Will Joint European Health Technology Assessment Provide Additional Benefits Over Individual Country-wise Assessments?	0
International overview of health technology assessment training tools and materials for patients and consumers	0
A technical review of the ISPOR Presentations Database: an update on changes to the database from the authors and ISPOR	0
OP107 Streamlining Health Technology Assessment Of Medical Devices Through Development Of The Philippine Essential Medical Device List	0
Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature	0
PP93 The Impact Of Using Different EQ-5D Scoring Methods On Cost-Utility Outcomes: A Simulation Study	0
Perceptions of patients and caregivers toward the management of rare disease in Malaysia: a qualitative research study	0
Implementation of a new Digi-HTA process for digital health technologies in Finland	0
PP428 Rechargeable Versus Recharge-Free Sacral Neurostimulation: An Australian Health Economics Analysis	0